Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates

Journal of Antimicrobial Chemotherapy

Volumn 45, Issue 2, 2000, Pages 167-173

  Descheemaeker, P ^a   Chapelle, S ^a   Lammens, C ^a   Hauchecorne, M ^a   Wijdooghe, M ^a   Vandamme, P ^b   Ieven, M ^a   Goossens, H ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; KETOLIDE; LINCOSAMIDE; MACROLIDE; MIOKAMYCIN; RESTRICTION ENDONUCLEASE; SPIRAMYCIN; TELITHROMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; CLONE; DRUG TARGETING; GENOME; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; STRAIN DIFFERENCE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 0033962264     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/45.2.167     Document Type: Article

References (43)

1. Bisno, A. L. (1991). Group A streptococcal infections and acute rheumatic fever. New England Journal of Medicine 325, 783-93.
2. Bisno, A. L. & Stevens, D. L. (1996). Streptococcal infections of skin and soft tissues. New England Journal of Medicine 334, 240-5.
3. Demers, B., Simor, A. E., Vellend, H., Schlievert, P. M., Byrne, S., Jamieson, F. et al. (1993). Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clinical Infectious Diseases 16, 792-800.
4. Denny, F. W. (1994). A 45-year perspective on the streptococcus and rheumatic fever: the Edward H. Kass lecture in infectious disease history. Clinical Infectious Diseases 19, 1110-22.
5. Stevens, D. L. (1992). Invasive group A streptococcus infections. Clinical Infectious Diseases 14, 2-11.
6. Lowbury, E. J. L. & Hurst, L. (1959). The sensitivity of staphylococci and other wound bacteria to erythromycin, oleandomycin, and spiramycin. Journal of Clinical Pathology 12, 163-9.
7. Gerber, M. A. (1996). Antibiotic resistance: relationship to persistence of group A streptococci in the upper respiratory tract. Pediatrics 97, 971-5.
8. Nakae, M., Murai, T., Kaneko, Y. & Mitsuhashi, S. (1977). Drug resistance in Streptococcus pyogenes isolated in Japan. Antimicrobial Agents and Chemotherapy 12, 427-8.
9. Miyamoto, Y., Takizawa, K., Matsushima, A., Asai, Y. & Nakatsuka, S. (1978). Stepwise acquisition of multiple drug resistance by beta-hemolytic streptococci and difference in resistance pattern by type. Prevalence of resistance to erythromycin in Japan. Antimicrobial Agents and Chemotherapy 13, 399-404.
10. Maruyama, S., Yoshioka, H., Fujita, K., Takimoto, M. & Satake, Y. (1979). Sensitivity of group A streptococci to antibiotics. Prevalence of resistance to erythromycin in Japan. American Journal of Diseases of Children 133, 1143-5.
11. Seppälä, H., Klaukka, T., Lehtonen, R., Nenonen, E. & Huovinen, P. (1995). Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci. Clinical Infectious Diseases 21, 1378-85.
12. Bass, J. W., Weisse, M. E., Plymyer, M. R., Murphy, S. & Eberly, B. J. (1994). Decline of erythromycin resistance of group A β-haemolytic streptococci in Japan. Comparison with worldwide reports. Archives of Pediatrics and Adolescent Medicine 148, 67-71.
13. Fujita, K., Murono, K., Yoshikawa, M. & Murai, T. (1994). Decline of erythromycin resistance of group A streptococci in Japan. Pediatric Infectious Disease Journal 13, 1075-8.
14. Berman, S. (1991). Epidemiology of acute respiratory infections in children of developing countries. Reviews of Infectious Diseases 13, Suppl. 6, 454-62.
15. Musher, D. M. (1992). Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity and treatment. Clinical Infectious Diseases 14, 801-7.
16. Appelbaum, P. C. (1992). Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clinical Infectious Diseases 15, 77-83.
17. Klugman, K. P. (1990). Pneumococcal resistance to antibiotics. Clinical Microbiology Reviews 3, 171-96.
18. Doern, G. J., Brueggemann, A., Holley, H. P. & Rauch, A. M. (1996). Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrobial Agents and Chemotherapy 40, 1208-13.
19. Geslin, P., Buu-Hoi, A., Fremaux, A. & Acar, J. F. (1992). Antimicrobial resistance in Streptococcus pneumoniae: an epidemiological survey in France, 1970-1990. Clinical Infectious Diseases 15, 95-8.
20. Leclercq, R. & Courvalin, P. (1991). Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrobial Agents and Chemotherapy 35, 1267-72, 2165 [Erratum].
21. Sutcliffe, J., Grebe, T., Tait-Kamradt, A. & Wondrack, L. (1996). Detection of erythromycin-resistant determinants by PCR. Antimicrobial Agents and Chemotherapy 40, 2562-6.
22. Seppälä, H., Skurnik, M., Soini, H., Roberts, M. C. & Huovinen, P. (1998). A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrobial Agents and Chemotherapy 42, 257-62.
23. Sutcliffe, J., Tait-Kamradt, A. & Wondrack, L. (1996). Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrobial Agents and Chemotherapy 40, 1817-24.
24. Seppälä, H., Nissinen, A., Yu, Q. & Huovinen, P. (1993). Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. Journal of Antimicrobial Chemotherapy 32, 885-91.
25. Clancy, J., Petitpas, J., Dib-Hajj, F., Yuan, W., Cronan, M., Kamath, A. V. et al. (1996). Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Molecular Microbiology 22, 867-79.
26. National Committee for Clinical Laboratory Standards. (1993). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Third Edition: Approved Standard M7-A3. NCCLS, Villanova, PA.
27. Pitcher, D. G., Saunders, N. A. & Owen, R. J. (1989). Rapid extraction of bacterial genomic DNA with guanidium thiocyanate. Letters in Applied Microbiology 8, 151-6.
28. Descheemaeker, P., Lammens, C., Pot, B., Vandamme, P. & Goossens, H. (1997). Evaluation of arbitrarily primed PCR analysis and pulsed field gel electrophoresis of large genomic DNA fragments for identification of enterococci important in human medicine. International Journal of Systematic Bacteriology 47, 555-61.
29. Kaufhold, A., Podbielski, A., Baumgarten, G., Blokpoel, M., Top, J. & Schouls, L. (1994). Rapid typing of group A streptococci by the use of DNA amplification and non-radioactive allele-specific oligonucleotide probes. FEMS Microbiology Letters 119, 19-25.
30. Perez-Trallero, E., Urbieta, M., Montes, M., Ayestaran, I. & Marimon, J. M. (1998). Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain. European Journal of Clinical Microbiology and Infectious Diseases 17, 25-31.
31. Orden, B., Perez-Trallero, E., Montes, M. & Martinez, R. (1998). Erythromycin resistance of Streptococcus pyogenes in Madrid. Pediatric Infection Disease Journal 17, 470-3.
32. Cornaglia, G., Ligozzi, M., Mazzariol, A., Valentini, M., Orefici, G. & Fontana, R. (1996). Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. The Italian Surveillance Group for Antimicrobial Resistance. Emerging Infectious Diseases 2, 339-42.
33. Cocuzza, C. E., Mattina, R., Mazzariol, A., Orefici, G., Rescaldani, R., Primavera, A. et al. (1997). High incidence of erythromycin-resistant Streptococcus pyogenes in Monza (North Italy) in untreated children with symptoms of acute pharyngo-tonsillitis: an epidemiological and molecular study. Microbial Drug Resistance 3, 371-8.
34. Cocuzza, C. E., Blandino, G., Mattina, R., Nicoletti, F. & Nicoletti, G. (1997). Antibiotic susceptibility of Group A streptococci in 2 Italian cities: Milano and Catania. Microbial Drug Resistance 3, 379-84.
35. Jasir, A. & Schalén, C. (1998). Survey of macrolide resistance phenotypes in Swedish clinical isolates of Streptococcus pyogenes. Journal of Antimicrobial Chemotherapy 41, 135-7.
36. Kriebernegg, I., Feierl, G., Grisold, A. & Marth, E. (1998). In-vitro susceptibility of group A beta-haemolytic streptococci (GABHS) to penicillin, erythromycin, clarithromycin and azithromycin in Styria, Austria. Zentralblatt für Bakteriologie 287, 33-9.
37. Kataja, J., Huovinen, P., Muotiala, A., Vuopio-Varkila, J., Efstratiou, A., Hallas, G. et al. (1998). Clonal spread of group A streptococcus with the new type of erythromycin resistance. Finnish Study Group for Antimicrobial Resistance. Journal of Infectious Diseases 177, 786-9.
38. Verhaegen, J., Glupczynski, Y., Verbist, L., Blogie, M., Verbiest, N., Vandeven, J. et al. (1995). Capsular types and antibiotic susceptibility of pneumococci isolated from patients in Belgium with serious infections, 1980-1993. Clinical Infectious Diseases 20, 1339-45.
39. Barry, A. L., Fuchs, P. C. & Brown, S. D. (1998). Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin) and a lincosamide (clindamycin). Antimicrobial Agents and Chemotherapy 42, 945-6.
40. Shortridge, V. D., Flamm, R. K., Ramer, N., Beyer, J. & Tanaka, S. K. (1996). Novel mechanism of macrolide resistance in Streptococcus pneumoniae. Diagnostic Microbiology and Infectious Disease 26, 73-8.
41. Johnston, N. J., De Azavedo, J. C., Kellner, J. D. & Low, D. E. (1998). Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 42, 2425-6.
42. Barry, A. L., Fuchs, P. C. & Brown, S. D. (1998). In vitro activities of the ketolide HMR 3647 against recent Gram-positive clinical isolates and Haemophilus influenzae. Antimicrobial Agents and Chemotherapy 42, 2138-40.
43. Agouridas, C., Collette, P., Mauvais, P. & Chantot, J. F. (1995). RU 004: preliminary studies on the mechanism of action. In Program and Abstracts of the Thirty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract F170, p. 142. American Society for Microbiology, Washington, DC.